• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利钠肽在初级保健中的作用:老年患者的探索性研究。

Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients.

机构信息

Department of Medicine, Skellefteå County Hospital, Skellefteå, Sweden.

出版信息

Scand J Prim Health Care. 2010 Mar;28(1):29-35. doi: 10.3109/02813430903345074.

DOI:10.3109/02813430903345074
PMID:20192890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3440611/
Abstract

OBJECTIVE

To explore the negative predictive value (NPV), positive predictive value (PPV), sensitivity, and specificity of natriuretic peptides, cut-off levels, and the impact of gender and age in elderly patients with systolic heart failure (HF).

DESIGN

Cross-sectional exploratory study.

SETTING

One primary healthcare centre.

PATIENTS

A total of 109 patients with symptoms of HF were referred for echocardiographic examination with a cardiovascular consultation. Systolic HF was diagnosed (ESC guidelines) in 48 patients (46% men, 54% women, mean age 79 years) while 61 patients (21% men, 79% women, mean age 76 years) had no HF.

MAIN OUTCOME MEASURES

NPV, PPV, sensitivity, specificity, and cut-off levels.

RESULTS

Including all 109 patients, NPV was 88% for NT-proBNP (200 ng/L) and 87% for BNP (20 pg/ml). PPV was 81% for NT-proBNP (500 ng/L) and 68% for BNP (50 pg/ml). Sensitivity was 96% for NT-proBNP (100 ng/L) and 96% for BNP (10-20 pg/ml). Specificity was 87% for NT-proBNP (500 ng/L) and 71% for BNP (50 pg/ml). Nt-proBNP (beta = 0.035; p < 0.001) and BNP (beta = 0.030; p < 0.001) were associated with age, but not with gender. In a multivariate analysis age (beta = 0.036; p < 0.001) and male gender (beta = 0.270; p = 0.014) were associated with NT-proBNP, but only age for BNP (beta = 0.030; p < 0.001).

CONCLUSION

Natriuretic peptides in an elderly population showed high NPVs, but not as high as in younger patients with HF in other studies. Age and male gender were associated with higher levels of NT-proBNP while only age was related to elevated BNP levels.

摘要

目的

探讨利钠肽在老年收缩性心力衰竭患者中的阴性预测值(NPV)、阳性预测值(PPV)、灵敏度和特异度、截断值以及性别和年龄的影响。

设计

横断面探索性研究。

地点

一个初级保健中心。

患者

共 109 例有心力衰竭症状的患者因心血管咨询行超声心动图检查而被转诊。根据 ESC 指南诊断为收缩性心力衰竭 48 例(46%为男性,54%为女性,平均年龄 79 岁),而无心力衰竭的 61 例(21%为男性,79%为女性,平均年龄 76 岁)。

主要观察指标

NPV、PPV、灵敏度、特异度和截断值。

结果

包括所有 109 例患者,NT-proBNP(200ng/L)的 NPV 为 88%,BNP(20pg/ml)的 NPV 为 87%。NT-proBNP(500ng/L)的 PPV 为 81%,BNP(50pg/ml)的 PPV 为 68%。NT-proBNP(100ng/L)的灵敏度为 96%,BNP(10-20pg/ml)的灵敏度为 96%。NT-proBNP(500ng/L)的特异度为 87%,BNP(50pg/ml)的特异度为 71%。NT-proBNP(β=0.035;p<0.001)和 BNP(β=0.030;p<0.001)与年龄相关,但与性别无关。多变量分析显示,年龄(β=0.036;p<0.001)和男性(β=0.270;p=0.014)与 NT-proBNP 相关,而只有年龄与 BNP 相关(β=0.030;p<0.001)。

结论

在老年人群中,利钠肽具有较高的 NPV,但不如其他研究中年轻的心力衰竭患者高。年龄和男性与 NT-proBNP 水平升高相关,而只有年龄与 BNP 水平升高相关。

相似文献

1
Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients.利钠肽在初级保健中的作用:老年患者的探索性研究。
Scand J Prim Health Care. 2010 Mar;28(1):29-35. doi: 10.3109/02813430903345074.
2
Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.脑利钠肽在基层医疗慢性心力衰竭临床诊断患者中的价值。
Scand Cardiovasc J. 2009;43(5):324-9. doi: 10.1080/14017430902769919.
3
The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.B型利钠肽检测在疑似心力衰竭社区患者人群中的诊断准确性及实用性。
Br J Gen Pract. 2006 May;56(526):327-33.
4
Comparative value of BNP and NT-proBNP in diagnosis of heart failure.BNP与NT-proBNP在心力衰竭诊断中的比较价值
Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91.
5
Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.B 型利钠肽在检测β-地中海贫血症患者隐匿性左心室舒张功能障碍中的预测价值。
Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.
6
Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.β受体阻滞剂和血管紧张素转换酶抑制剂对稳定型收缩性心力衰竭患者B型利钠肽的影响。
Cardiovasc Drugs Ther. 2008 Aug;22(4):305-11. doi: 10.1007/s10557-008-6099-6. Epub 2008 Feb 29.
7
[Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].[目前使用的标准及脑钠肽对先天性心脏病患儿充血性心力衰竭的诊断价值]
Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):728-32.
8
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭和射血分数降低患者中 BNP 和 NT-proBNP 的比较。
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
9
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure.NT-proBNP 的预后价值在老年和极老年慢性收缩性心力衰竭患者中得以维持。
Int J Cardiol. 2018 Nov 15;271:324-330. doi: 10.1016/j.ijcard.2018.04.006.
10
Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.血浆脑钠肽在鉴别充血性心力衰竭患者与其他疾病中的作用。
J Med Assoc Thai. 2003 May;86 Suppl 1:S87-95.

引用本文的文献

1
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure.血清可溶性ST2是急性心力衰竭患者重要的预后生物标志物。
Front Cardiovasc Med. 2022 Feb 9;9:812654. doi: 10.3389/fcvm.2022.812654. eCollection 2022.
2
Diagnostic rules and algorithms for the diagnosis of non-acute heart failure in patients 80 years of age and older: a diagnostic accuracy and validation study.80 岁及以上老年人非急性心力衰竭的诊断规则和算法:一项诊断准确性和验证研究。
BMJ Open. 2016 Oct 6;6(10):e012888. doi: 10.1136/bmjopen-2016-012888.
3
Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.N末端脑钠肽前体作为排除高龄且有呼吸困难老年人左心室功能障碍检查的效用:纽卡斯尔85岁及以上人群研究
BMC Cardiovasc Disord. 2014 Sep 26;14:128. doi: 10.1186/1471-2261-14-128.
4
Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.B型利钠肽(BNP)和N末端B型利钠肽原(NT-proBNP)在基层医疗患者心力衰竭诊断中的性能:一项系统评价
Heart Fail Rev. 2014 Aug;19(4):439-51. doi: 10.1007/s10741-014-9445-8.

本文引用的文献

1
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).《2008年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2008年急性和慢性心力衰竭诊断与治疗特别工作组制定。与欧洲心脏病学会心力衰竭协会(HFA)合作编写,并得到欧洲重症医学学会(ESICM)认可。
Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17.
2
Are elderly patients with suspected HF misdiagnosed? A primary health care center study.疑似心力衰竭的老年患者是否被误诊?一项初级卫生保健中心研究。
Cardiology. 2007;107(4):226-32. doi: 10.1159/000095422. Epub 2006 Sep 1.
3
The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.B型利钠肽检测在疑似心力衰竭社区患者人群中的诊断准确性及实用性。
Br J Gen Pract. 2006 May;56(526):327-33.
4
Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives.B型利钠肽检测的临床应用:现状与未来展望。
Heart. 2005 Nov;91(11):1489-94. doi: 10.1136/hrt.2005.063784.
5
Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.N末端脑钠肽前体在疑似心力衰竭初级护理患者中的诊断及预后评估价值
J Card Fail. 2005 Jun;11(5 Suppl):S15-20. doi: 10.1016/j.cardfail.2005.04.022.
6
The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study.血浆脑钠肽(BNP)和N末端脑钠肽原(NTproBNP)对基层医疗转诊的疑似心力衰竭患者的诊断准确性:英国利钠肽研究结果
Eur J Heart Fail. 2005 Jun;7(4):537-41. doi: 10.1016/j.ejheart.2005.01.022.
7
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.慢性心力衰竭诊断和治疗指南:执行摘要(2005年更新):欧洲心脏病学会慢性心力衰竭诊断和治疗特别工作组
Eur Heart J. 2005 Jun;26(11):1115-40. doi: 10.1093/eurheartj/ehi204. Epub 2005 May 18.
8
N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.健康献血者以及来自全科医生处的、已诊断和未诊断出心脏病的患者体内的N端前脑钠肽(NT-proBNP)
Clin Lab. 2005;51(3-4):167-72.
9
Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?脑钠肽(BNP)能否作为全科医疗中的一种筛查工具?
Scand J Prim Health Care. 2004 Sep;22(3):187-90. doi: 10.1080/02813430410006594.
10
Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).卡维地洛对舒张性心力衰竭且收缩功能保留患者舒张功能的影响。瑞典多普勒超声心动图研究(SWEDIC)结果。
Eur J Heart Fail. 2004 Jun;6(4):453-61. doi: 10.1016/j.ejheart.2004.02.003.